The new protein that is generated, called γ-heregulin, is controlled by the ODZ4 promoter, and this fusion protein promotes cancer cell proliferation by constitutively activating the HER3–HER2 complex via γ-heregulin-dependent autocrine stimulation [68]. This evidence concerns the gene TENM4 and cancer.